Cisplatin-Based Chemotherapy May Cause Hearing Loss in Cancer Survivors
Tiragolumab Combo Does Not Reach Survival End Points in Nonsquamous NSCLC
Developers intend to halt the phase 2/3 SKYSCRAPER-06 trial assessing tiragolumab plus atezolizumab and chemotherapy in nonsquamous NSCLC.
GTB-3650 Snags FDA Clearance for IND Application in CD33+ Leukemia
Investigators will assess the clinical activity, safety, and pharmacokinetics of GTB-3650 among those with CD33-expressing cancers in a phase 1 trial.
Videos
Supportive Care Strategies for CAR T-Cell Therapy Recipients
Experts on multiple myeloma provide clinical insights on supportive care strategies for patients experiencing infections or secondary malignancies following CAR T-cell therapy.
Watch Now
TKIs, Disease Progression and Subsequent Therapy in RCC
Key opinion leaders examine the application of tyrosine kinase inhibitors (TKIs) and evaluate first-line therapeutic approaches for renal cell carcinoma.
Watch Now
Trending
Tanya B. Dorff, MD, on Results From Phase 1 CAR T-Cell Therapy mCRPC Trial
Findings from a phase 1 study may inform future trial designs intended to yield longer responses with PSCA-targeted CAR T cells.
Acalabrutinib Appears More Effective in Earlier Lines of Treatment for CLL
A pooled analysis trial assessed the impact of acalabrutinib in patients with chronic lymphocytic leukemia across treatment lines.
